Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Bought by Dundas Partners LLP

Dundas Partners LLP lifted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 24.7% during the 4th quarter, HoldingsChannel reports. The firm owned 10,254 shares of the company’s stock after purchasing an additional 2,029 shares during the quarter. Dundas Partners LLP’s holdings in Ryan Specialty were worth $658,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Hollencrest Capital Management acquired a new stake in Ryan Specialty during the third quarter worth about $25,000. Assetmark Inc. purchased a new stake in shares of Ryan Specialty in the 3rd quarter valued at approximately $34,000. Principal Securities Inc. raised its holdings in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after buying an additional 415 shares during the period. Quarry LP boosted its position in Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after buying an additional 422 shares during the period. Finally, Loomis Sayles & Co. L P grew its position in shares of Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after buying an additional 286 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on RYAN shares. Royal Bank of Canada dropped their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research note on Friday, February 21st. UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Wells Fargo & Company raised their target price on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Barclays increased their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Finally, Morgan Stanley started coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $75.27.

Insider Buying and Selling at Ryan Specialty

In other news, Director Nicholas Dominic Cortezi sold 31,409 shares of the firm’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the transaction, the director now directly owns 2,697 shares of the company’s stock, valued at approximately $177,031.08. This trade represents a 92.09 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last three months, insiders have sold 316,451 shares of company stock worth $20,907,793. 11.10% of the stock is owned by insiders.

Ryan Specialty Stock Up 0.1 %

Shares of NYSE:RYAN opened at $69.31 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97. The company has a 50 day moving average of $66.57 and a two-hundred day moving average of $67.59. The company has a market capitalization of $18.15 billion, a price-to-earnings ratio of 100.45, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. As a group, analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.69%. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Tuesday, March 4th. Ryan Specialty’s dividend payout ratio (DPR) is presently 69.57%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.